Mosby's 2023 Nursing Drug Reference

Mosby's 2023 Nursing Drug Reference

by Linda Skidmore-Roth RN, MSN, NP
Mosby's 2023 Nursing Drug Reference

Mosby's 2023 Nursing Drug Reference

by Linda Skidmore-Roth RN, MSN, NP

Paperback(36th ed.)

$34.99  $46.99 Save 26% Current price is $34.99, Original price is $46.99. You Save 26%.
  • SHIP THIS ITEM
    Qualifies for Free Shipping
    Choose Expedited Shipping at checkout for delivery by Wednesday, April 3
  • PICK UP IN STORE
    Check Availability at Nearby Stores

Related collections and offers


Overview

Choose the drug handbook trusted by nurses for more than 35 years! Mosby's 2023 Nursing Drug Reference makes it easy to find the most vital information on the drugs you administer most frequently. More than 5,000 drugs are profiled — including 35 new entries for drugs recently approved by the FDA. And no other drug guide places a higher emphasis on patient safety, with Black Box Warnings for dangerous adverse reactions, Safety Alerts for situations requiring special attention, and a focus on both common and life-threatening side effects. From nursing pharmacology expert Linda Skidmore-Roth, this perennial bestseller proves there is a difference in drug guides.

  • More than 5,000 generic and trade-name drugs are profiled, covering almost every drug you will administer in practice or in clinicals.
  • Safety Alert icon highlights the most critical drug interactions and side effects.
  • Black Box Warnings provide alerts to FDA warnings of dangerous or life-threatening drug reactions.
  • Nursing Process steps are used as the framework for organizing all nursing care information.
  • Coverage of IV drug administration highlights dosage and IV administration instructions, including safety considerations and Y-site, syringe, and additive compatibilities.
  • Side effects information is organized by body system and identified as common or life threatening, showing signs to watch for during assessments.
  • Alphabetical organization by generic name provides quick and easy access to specific drugs, and a full-color design highlights important information.
  • Complete pharmacokinetic information includes the mechanism and absorption of the drug as well as its action, duration, and excretion.
  • Overview of drug categories explains the safe administration of common classes of drugs, as well as their common side effects and interactions.
  • Flexible, water-resistant cover provides durability in the clinical setting.
  • NEW! Drug monographs for 35 new FDA-approved medications equip you with the latest drug information including generic names, trade names, pronunciations, do-not-confuse drugs, action, uses, contraindications, precautions, dosages and routes, side effects, pharmacokinetics, interactions (including drug/herb, drug/food and drug/lab test), nursing considerations, treatment of overdose, patient/family teaching, and more.
  • NEW! Updates on drug therapies provide the most current information.

Product Details

ISBN-13: 9780323930727
Publisher: Elsevier Health Sciences
Publication date: 06/21/2022
Series: Skidmore Nursing Drug Reference
Edition description: 36th ed.
Pages: 1504
Sales rank: 153,090
Product dimensions: 4.40(w) x 7.30(h) x 2.10(d)

About the Author

Linda Skidmore-Roth, RN, MSN, NP has been the lead author of Mosby’s Nursing Drug Reference for more than 25 years and as such is synonymous with the Mosby imprint as a trusted name in nursing pharmacology information

Table of Contents

INDIVIDUAL DRUG MONOGRAPHS
APPENDIXES

A. Selected New Drugs abametapir aducanumab-avwa afamelanotide anifrolumab-fnia asciminib atogepant avacopan avapritinib belumosudil belzutifan bempedoic acid brolucizumab-dbll difelikefalin dostarlimab-gxly eculizumab efavirenz/emtricitabine/tenofovir elapegademase-ivir elbasvir/grazoprevir elexacaftor/tezacaftor/ivacaftor and ivacaftor emtricitabine/rilpivirine/tenofovir alafenamide enalapril/hydrochlorothiazide ephedrine factor IX complex factor IX, human factor IX, recombinant finerenone fluocinolone fluocinonide lonapegsomatropin-tcgd loncastuximab tesirine-lpyl maribavir mobocertinib odevixibat ropeginterferon alfa-2b tisotumab vedotin-tftv vosoritide
B. Ophthalmic, Nasal, Topical, and Otic Products
C. Vaccines and Toxoids
D. Recent FDA Drug Approvals
INDEX
EVOLVE WEBSITE

• Additional Monographs
• Drug Categories

What People are Saying About This

From the Publisher

Mosby’s bestselling drug reference for nurses — from the most trusted name in nursing

From the B&N Reads Blog

Customer Reviews